Macro ChallengesDue to some challenges at the macro level in life sciences, modest current expected top-line growth, and the stock's premium valuation relative to its small cap peer group, the Neutral rating on TKNO is maintained.
Market UncertaintyCautiousness from customers related to the funding environment and other macro uncertainties are important considerations that management confirmed are baked into the low end of the guide.
Valuation ConcernsShares of TKNO trade at a premium to the small cap tools peer group.